Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy

被引:16
作者
Busca, Alessandro [1 ]
Marmont, Filippo [1 ]
Locatelli, Franco [1 ]
Limerutti, Giorgio [2 ]
Sorrentino, Maria Teresa [2 ]
Barbui, Anna [3 ]
Patrono, Damiano [4 ]
Salizzoni, Mauro [4 ]
David, Ezio [5 ]
De Rosa, Francesco [6 ]
机构
[1] San Giovanni Battista Hosp, Dept Hematol, I-10126 Turin, Italy
[2] San Giovanni Battista Hosp, Serv Radiol 1, I-10126 Turin, Italy
[3] San Giovanni Battista Hosp, Microbiol Lab, I-10126 Turin, Italy
[4] Univ Turin, San Giovanni Battista Hosp, Gen Surg & Liver Transplantat Ctr 8, Turin, Italy
[5] San Giovanni Battista Hosp, Dept Pathol, Turin, Italy
[6] Univ Turin, Amedeo di Savoia Hosp, Dept Infect Dis, Turin, Italy
关键词
D O I
10.1111/j.1439-0507.2009.01708.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P>We describe the case of a 19-year-old boy with acute leukaemia who developed primary hepatic zygomycosis. The patient presented with febrile neutropenia and severe abdominal tenderness. Despite the administration of antibiotics and liposomal Amphotericin-B (L-AmB), the CT scan demonstrated an increase in the size of liver lesions. A wide surgical resection was carried out and liver specimens demonstrated a branching, filamentous fungus that was identified as Rhizomucor pusillus by both phenotypic and molecular methods. The patient was treated with L-AmB combined with posaconazole, and deferasirox was subsequently added given the potential synergistic effect of this iron chelator in combination with L-AmB. Three months after surgical intervention, an allogeneic stem-cell transplantation was successfully carried out. The present case confirms that an early surgical management combined with antifungal agents is crucial to optimise the outcome of patients with zygomycosis and the use of deferasirox is a promising alternative.
引用
收藏
页码:275 / 278
页数:4
相关论文
empty
未找到相关数据